These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 28413156)
1. Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies. Combs B; Kanaan NM Am J Pathol; 2017 Jun; 187(6):1222-1229. PubMed ID: 28413156 [TBL] [Abstract][Full Text] [Related]
2. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies. Combs B; Hamel C; Kanaan NM Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838 [TBL] [Abstract][Full Text] [Related]
3. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231 [TBL] [Abstract][Full Text] [Related]
4. Selective tau tyrosine nitration in non-AD tauopathies. Reyes JF; Geula C; Vana L; Binder LI Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Early Pathological Tau Conformations and Phosphorylation in Chronic Traumatic Encephalopathy. Kanaan NM; Cox K; Alvarez VE; Stein TD; Poncil S; McKee AC J Neuropathol Exp Neurol; 2016 Jan; 75(1):19-34. PubMed ID: 26671985 [TBL] [Abstract][Full Text] [Related]
7. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid. Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation and cleavage of tau in non-AD tauopathies. Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802 [TBL] [Abstract][Full Text] [Related]
12. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854 [TBL] [Abstract][Full Text] [Related]
18. [Tau isoforms and neurodegenerative disorders]. Wada K; Wakutani Y; Nakashima K No To Shinkei; 2002 Sep; 54(9):767-76. PubMed ID: 12428363 [No Abstract] [Full Text] [Related]
19. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387 [TBL] [Abstract][Full Text] [Related]
20. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]